Artibani, M., Masuda, K., Hu, Z., Rauher, P., Mallett, G., Wietek, N., . . . Ahmed, A. (2021). Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells. American Society for Clinical Investigation.
Chicago Style (17th ed.) CitationArtibani, M., et al. Adipocyte-like Signature in Ovarian Cancer Minimal Residual Disease Identifies Metabolic Vulnerabilities of Tumor Initiating Cells. American Society for Clinical Investigation, 2021.
MLA (9th ed.) CitationArtibani, M., et al. Adipocyte-like Signature in Ovarian Cancer Minimal Residual Disease Identifies Metabolic Vulnerabilities of Tumor Initiating Cells. American Society for Clinical Investigation, 2021.
Warning: These citations may not always be 100% accurate.